Literature DB >> 18458816

Assessment of a balloon-tipped catheter modified for intracerebral convection-enhanced delivery.

Jeffrey J Olson1, Zhaobin Zhang, Dirk Dillehay, James Stubbs.   

Abstract

Numerous improvements in the understanding of the biology of primary brain tumors have been reported. The resultant application of this information to the therapy of these lesions offers promising alternatives. For any of a number of reasons delivery of these therapies to the target neoplasm can be challenging. Convection enhanced delivery has been established as a modality that has been shown to circumvent some of the impediments to treatment agent delivery. This report described the preliminary preclinical use of a balloon tipped catheter with a channel built in for infusion of therapy directly into the brain. A series of 10 canines were studied using bolus and continuous infusions with the balloon either inflated or deflated. The infusates contained gadolinium to allow imaging of the convection process. The character of the cerebral penetration is described ranging from minimal cerebral penetration with uninflated balloons used with bolus injections to extensive bilateral penetration using inflated balloons and continuous infusions. This data demonstrates the feasibility and potential value of such a system and warrants a more detailed analysis of the device using a wider variety of infusion parameters, assessment of larger infusate molecule sizes likely to be solely dependent on convection and direct comparison to standard catheter convection techniques.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18458816     DOI: 10.1007/s11060-008-9612-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  21 in total

1.  Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics.

Authors:  P F Morrison; M Y Chen; R S Chadwick; R R Lonser; E H Oldfield
Journal:  Am J Physiol       Date:  1999-10

Review 2.  The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery.

Authors:  D R Groothuis
Journal:  Neuro Oncol       Date:  2000-01       Impact factor: 12.300

Review 3.  Mechanisms of glioma invasion: role of matrix-metalloproteinases.

Authors:  J H Uhm; N P Dooley; J G Villemure; V W Yong
Journal:  Can J Neurol Sci       Date:  1997-02       Impact factor: 2.104

4.  Direct delivery of medication into a brain tumor through multiple chronically implanted catheters.

Authors:  G Bouvier; R D Penn; J S Kroin; R Beique; M J Guerard
Journal:  Neurosurgery       Date:  1987-02       Impact factor: 4.654

Review 5.  Convection-enhanced delivery in the treatment of malignant glioma.

Authors:  Kim A Lopez; Allen E Waziri; Peter D Canoll; Jeffrey N Bruce
Journal:  Neurol Res       Date:  2006-07       Impact factor: 2.448

Review 6.  CNS drug design based on principles of blood-brain barrier transport.

Authors:  W M Pardridge
Journal:  J Neurochem       Date:  1998-05       Impact factor: 5.372

7.  Convection-enhanced delivery of macromolecules in the brain.

Authors:  R H Bobo; D W Laske; A Akbasak; P F Morrison; R L Dedrick; E H Oldfield
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

8.  Biodistribution and dosimetry of an aqueous solution containing sodium 3-(125I)iodo-4-hydroxybenzenesulfonate (Iotrex) for brachytherapy of resected malignant brain tumors.

Authors:  J B Stubbs; A D Strickland; R K Frank; J Simón; K McMillan; J A Williams
Journal:  Cancer Biother Radiopharm       Date:  2000-12       Impact factor: 3.099

9.  Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors.

Authors:  D W Laske; R J Youle; E H Oldfield
Journal:  Nat Med       Date:  1997-12       Impact factor: 53.440

10.  Antisense Oligodeoxynucleotide Technology: Potential Use for the Treatment of Malignant Brain Tumors.

Authors: 
Journal:  Cancer Control       Date:  1998-03       Impact factor: 3.302

View more
  12 in total

Review 1.  Convection-Enhanced Delivery.

Authors:  A M Mehta; A M Sonabend; J N Bruce
Journal:  Neurotherapeutics       Date:  2017-04       Impact factor: 7.620

Review 2.  Convection-enhanced delivery for glioblastoma: targeted delivery of antitumor therapeutics.

Authors:  Timothy H Ung; Hani Malone; Peter Canoll; Jeffrey N Bruce
Journal:  CNS Oncol       Date:  2015-06-24

Review 3.  Convection-Enhanced Delivery in Children: Techniques and Applications.

Authors:  K Aquilina; A Chakrapani; L Carr; M A Kurian; D Hargrave
Journal:  Adv Tech Stand Neurosurg       Date:  2022

4.  Comparison of pulsed versus continuous convective flow for central nervous system tissue perfusion: laboratory investigation.

Authors:  Edjah K Nduom; Stuart Walbridge; Russell R Lonser
Journal:  J Neurosurg       Date:  2012-10-12       Impact factor: 5.115

Review 5.  Convection-enhanced delivery for the treatment of brain tumors.

Authors:  Waldemar Debinski; Stephen B Tatter
Journal:  Expert Rev Neurother       Date:  2009-10       Impact factor: 4.618

6.  Regional convection-enhanced delivery of gadolinium-labeled albumin in the rat hippocampus in vivo.

Authors:  Garrett W Astary; Svetlana Kantorovich; Paul R Carney; Thomas H Mareci; Malisa Sarntinoranont
Journal:  J Neurosci Methods       Date:  2010-01-11       Impact factor: 2.390

Review 7.  Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies.

Authors:  Arman Jahangiri; Aaron T Chin; Patrick M Flanigan; Rebecca Chen; Krystof Bankiewicz; Manish K Aghi
Journal:  J Neurosurg       Date:  2016-04-01       Impact factor: 5.115

Review 8.  Diphtheria toxin-based targeted toxin therapy for brain tumors.

Authors:  Yan Michael Li; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2013-05-22       Impact factor: 4.130

9.  Electrokinetic infusions into hydrogels and brain tissue: Control of direction and magnitude of solute delivery.

Authors:  Amir H Faraji; Andrea S Jaquins-Gerstl; Alec C Valenta; Stephen G Weber
Journal:  J Neurosci Methods       Date:  2018-10-09       Impact factor: 2.390

10.  Intracerebral infusion of the bispecific targeted toxin DTATEGF in a mouse xenograft model of a human metastatic non-small cell lung cancer.

Authors:  Jun Huang; Yan Michael Li; Joan Massague; Andy Sicheneder; Daniel A Vallera; Walter A Hall
Journal:  J Neurooncol       Date:  2012-06-14       Impact factor: 4.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.